Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Karim Fizazi, Howard I. Scher, Arturo Molina, Christopher J. Logothetis, Kim N., Robert J. Jones, John Staffurth, Scott North, Nicholas J. Vogelzang, Fred Saad,

The Lancet Oncology · 2012 · 1.4K citations · 30 references

Concepts

References

30